Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445–56.
Article CAS PubMed Google Scholar
Mochizuki K. Is ophthalmic consultations really necessary in patients with candidemia? Med Mycol J. 2023;64:83–5. https://doi.org/10.11534/ishinkin.23.006 (in Japanese).
Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53:262–8.
Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, et al. The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia. PLoS ONE. 2019;14: e0216956.
Article CAS PubMed PubMed Central Google Scholar
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-50.
Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, et al. Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014. Med Mycol J. 2016;57:E117–63.
Breazzano MP, Day HR Jr, Bloch KC, Tanaka S, Cherney EF, Sternberg P, et al. Utility of ophthalmologic screening for patients with candida bloodstream infections: a systematic review. JAMA Ophthalmol. 2019;137:698–710.
Breazzano MP, Bond JB 3rd, Bearelly S, Kim DH, Donahue SP, Lum F, et al. American academy of ophthalmology recommendations on screening for endogenous Candida endophthalmitis. Ophthalmology. 2022;129:73–6.
Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302–9.
Article CAS PubMed Google Scholar
Kato H, Yoshimura Y, Suido Y, Ide K, Sugiyama Y, Matsuno K, et al. Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection. Infection. 2018;46:635–40.
Seidelman J, Fleece M, Bloom A, Lydon E, Yang W, Arnold C, et al. Endogenous Candida endophthalmitis: who is really at risk? J Infect. 2021;82(2):276–81.
Shin SU, Yu YH, Kim SS, Oh TH, Kim SE, Kim UJ, et al. Clinical characteristics and risk factors for complications of candidaemia in adults: focus on endophthalmitis, endocarditis, and osteoarticular infections. Int J Infect Dis. 2020;93:126–32.
Kim JH, Suh JW, Kim JY, Kim SB, Yoon YK, Sohn JW, et al. Prevalence and risk factors for endogenous fungal endophthalmitis in adult patients with candidemia at a tertiary care hospital in the Republic of Korea over 13 years. J Mycol Med. 2021;31(1): 101102.
Paulus YM, Cheng S, Karth PA, Leng T. Prospective trial of endogenous fungal endophthalmitis and chorioretinitis rates, clinical course, and outcomes in patients with fungemia. Retina. 2016;36:1357–63.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Article CAS PubMed Google Scholar
Rodríguez-Adrián LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187–202.
Blennow O, Tallstedt L, Hedquist B, Gårdlund B. Duration of treatment for candidemia and risk for late-onset ocular candidiasis. Infection. 2013;41:129–34.
Article CAS PubMed Google Scholar
Phongkhun K, Pothikamjorn T, Srisurapanont K, Manothummetha K, Sanguankeo A, Thongkam A, et al. Prevalence of ocular candidiasis and Candida endophthalmitis in patients with candidemia: a systematic review and meta-analysis. Clin Infect Dis. 2023;76:1738–49.
Comments (0)